| Secondary |
| Type 2 Diabetes Mellitus |
73.1% |
| Product Used For Unknown Indication |
16.4% |
| Diabetes Mellitus |
6.0% |
| Suicide Attempt |
3.0% |
| Hypertension |
1.5% |
|
| Hiv Infection |
37.5% |
| Pneumocystis Jiroveci Pneumonia |
18.8% |
| Rhabdomyolysis |
12.5% |
| Hyponatraemia |
6.3% |
| Pneumocystis Jirovecii Pneumonia |
6.3% |
| Renal Impairment |
6.3% |
| Stridor |
6.3% |
| Suicide Attempt |
6.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.2% |
| Hypertension |
17.5% |
| Diabetes Mellitus |
14.4% |
| Drug Use For Unknown Indication |
6.1% |
| Chronic Myeloid Leukaemia |
4.5% |
| Rheumatoid Arthritis |
4.1% |
| Type 2 Diabetes Mellitus |
4.0% |
| Atrial Fibrillation |
2.9% |
| Colitis Ulcerative |
2.7% |
| Colorectal Cancer Metastatic |
2.6% |
| Hiv Infection |
2.4% |
| Prophylaxis |
1.9% |
| Aspergillosis |
1.8% |
| Arrhythmia |
1.6% |
| Hypercholesterolaemia |
1.4% |
| Gastritis |
1.3% |
| Oedema |
1.3% |
| Prophylaxis Against Transplant Rejection |
1.3% |
| Cerebrovascular Accident |
1.1% |
| Cerebrovascular Accident Prophylaxis |
1.1% |
|
| Sepsis |
9.3% |
| Death |
7.0% |
| Renal Failure Acute |
7.0% |
| Varicose Vein |
7.0% |
| Weight Decreased |
7.0% |
| Melaena |
5.8% |
| Pneumonia |
5.8% |
| Liver Function Test Abnormal |
4.7% |
| Oedema |
4.7% |
| Polydipsia |
4.7% |
| Somnolence |
4.7% |
| Ureteral Stent Insertion |
4.7% |
| Liver Disorder |
3.5% |
| Lymphopenia |
3.5% |
| Renal Impairment |
3.5% |
| Swelling |
3.5% |
| Transplant Rejection |
3.5% |
| Urinary Tract Infection |
3.5% |
| Vision Blurred |
3.5% |
| Visual Impairment |
3.5% |
|
| Interacting |
| Hypertension |
62.5% |
| Type 2 Diabetes Mellitus |
25.0% |
| Cardiovascular Event Prophylaxis |
12.5% |
|
| Shock Hypoglycaemic |
100.0% |
|
